Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 5

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
,549) 
     (752) 
     (1,877,301)
  
    Share rounding adjustment for reverse stock split 
     -  
     -  
     (38) 
     -  
     -  
        
     -  
     -  
     -  
     - 
  
    Balance— March 31, 2025 
     76,480  
    $9,567,439  
     1,472,891  
    $147  
    $36,821,588  
    $(42,404,506) 
    $125,567  
    $4,110,235  
    $(81,346) 
    $4,028,889 

(1)Prior periods presented have been adjusted to reflect the
1:5 reverse stock split on February 24, 2025.

3

    For the Three Months Ended March 31, 2024 

     Series A Preferred Stock  
    Common Stock(1)  
    Additional Paid-In  
    Accumulated  
    Accumulated
Other  Comprehensive  
    Total Shareholders’
    Equity Attributable  
    Noncontrolling  Interest on  
    Total  Shareholders’ 

    Shares  
    Amount  
    Shares  
    Amount  
     Capital(1)  
     Deficit  
    Income (Loss)  
     to 60P  
     Shareholders  
    Equity 

    Balance—December 31, 2023 
     78,803  
    $9,858,040  
     96,847  
    $10  
    $27,457,373  
    $(32,580,850) 
    $135,561  
    $4,870,134  
    $(72,038) 
    $4,798,096 
  
    Issuance of common stock and warrants, net of underwriting discounts and offering costs paid at closing and deferred offering costs (Note 6) 
     -  
     -  
     87,683  
     9  
     1,898,287  
     -  
     -  
     1,898,296  
     -  
     1,898,